Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
about
Diabetes Mellitus as Hub for Tuberculosis Infection: A SnapshotImmune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesInfluence of diabetes mellitus on the immunity to human tuberculosis.Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsDiabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and MetaanalysisDiminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infectionCoincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosisImpact of diabetes on the natural history of tuberculosis.Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia.The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.VDR, RXR, Coronin-1 and Interferonγ Levels in PBMCs of Type-2 Diabetes Patients: Molecular Link between Diabetes and TuberculosisNK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection.Increased risk of tuberculosis in patients with type 1 diabetes mellitus: results from a population-based cohort study in TaiwanClinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters.Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting.Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria
P2860
Q28077839-35F62548-CCA1-4652-AFDD-C31E57F04FEEQ28081001-E4F201DF-7F9A-4413-A0F2-38CA0686CA5EQ30234363-FF012823-DDF8-46CA-A38D-8C933B78B35BQ30234697-65E6DBC2-6E09-418D-AA64-5B45E8B188ECQ30371980-4B04CA28-1388-4645-AAF0-09704E80179EQ33589264-3062E3E0-6D5B-4C4A-B565-8485C6436E77Q34430226-1C726661-A9EF-4619-BD00-2E21B077ED79Q34505943-ABB9681E-CA01-495F-95BE-940E57DB5036Q34663669-4BB67ECB-FD78-4EF2-80B8-F5BF21FE8B7BQ35132249-E36336DC-354A-4C31-90A4-0351A1FEF14EQ35558240-F8206A68-2195-4F42-A2C9-981ADCBB0360Q35663649-A8BF8A72-D3DF-44F7-8854-401CBB182400Q35747127-4E3FC30D-0337-409B-82A3-C21490E30EB4Q36175034-535A3B9D-9CAE-4E62-8F8E-D651C6F11AF3Q36193450-B2D81A32-0F72-4824-BA24-00A96F8AFD19Q36290609-AF3500AB-A932-4E85-9AB8-CE16EF82B23CQ36338729-75B14593-5BB5-4519-B2DF-785F92294C9FQ39310832-91D82C8B-E701-4386-9898-4361B371BCDFQ40043410-CD23EF2C-E531-41EF-A31F-E0A20709496FQ40187771-FF1007E4-5F2C-4367-8D01-134532F13BBEQ40438875-7DFCADC3-B900-4E81-A3A7-5258E9FE10F7Q40495966-FA9A743B-F478-44B1-8284-BB8CCF830433Q40815734-B736BE66-22A5-4712-B02C-F891A8179D4BQ46316702-ECFFD96B-E9B1-4667-BB8F-41BF55480367Q47548481-741798B4-DD23-4042-B7B8-50E0D97AB58FQ49572596-AEA60991-CC74-4C5A-ACFF-11A447DEBFF3Q58602010-49FE4A1C-7582-4FEF-B01E-2477FC8F0004
P2860
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@ast
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@en
type
label
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@ast
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@en
prefLabel
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@ast
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@en
P2860
P1433
P1476
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.
@en
P2093
Blanca I Restrepo
Larry S Schlesinger
P2860
P356
10.1016/S1472-9792(13)70004-0
P478
P577
2013-12-01T00:00:00Z